These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

309 related items for PubMed ID: 22550060

  • 1. Intensity-modulated radiation therapy with concurrent carboplatin and paclitaxel for locally advanced head and neck cancer: toxicities and efficacy.
    Vlacich G, Diaz R, Thorpe SW, Murphy BA, Kirby W, Sinard RJ, Shakhtour B, Shyr Y, Murphy P, Netterville JL, Yarbrough WG, Cmelak AJ.
    Oncologist; 2012; 17(5):673-81. PubMed ID: 22550060
    [Abstract] [Full Text] [Related]

  • 2. The evaluation of amifostine for mucosal protection in patients with advanced loco-regional squamous cell carcinomas of the head and neck (SCCHN) treated with concurrent weekly carboplatin, paclitaxel, and daily radiotherapy (RT).
    Suntharalingam M, Jaboin J, Taylor R, Wolf J, Banglore M, Van Echo D, Ord R.
    Semin Oncol; 2004 Dec; 31(6 Suppl 18):2-7. PubMed ID: 15726515
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Phase I study of weekly nab-paclitaxel + weekly cetuximab + intensity-modulated radiation therapy (IMRT) in patients with stage III-IVB head and neck squamous cell carcinoma (HNSCC).
    Fury MG, Sherman EJ, Rao SS, Wolden S, Smith-Marrone S, Mueller B, Ng KK, Dutta PR, Gelblum DY, Lee JL, Shen R, Kurz S, Katabi N, Haque S, Lee NY, Pfister DG.
    Ann Oncol; 2014 Mar; 25(3):689-694. PubMed ID: 24496920
    [Abstract] [Full Text] [Related]

  • 5. Intensity-modulated radiation therapy in advanced head and neck patients treated with intensive chemoradiotherapy: preliminary experience and future directions.
    Milano MT, Vokes EE, Kao J, Jackson W, List MA, Stenson KM, Witt ME, Dekker A, MacCracken E, Garofalo MC, Chmura SJ, Weichselbaum RR, Haraf DJ.
    Int J Oncol; 2006 May; 28(5):1141-51. PubMed ID: 16596230
    [Abstract] [Full Text] [Related]

  • 6. The use of carboplatin and paclitaxel with daily radiotherapy in patients with locally advanced squamous cell carcinomas of the head and neck.
    Suntharalingam M, Haas ML, Conley BA, Egorin MJ, Levy S, Sivasailam S, Herman JM, Jacobs MC, Gray WC, Ord RA, Aisner JA, Van Echo DA.
    Int J Radiat Oncol Biol Phys; 2000 Apr 01; 47(1):49-56. PubMed ID: 10758304
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Phase II study evaluating the addition of cetuximab to the concurrent delivery of weekly carboplatin, paclitaxel, and daily radiotherapy for patients with locally advanced squamous cell carcinomas of the head and neck.
    Suntharalingam M, Kwok Y, Goloubeva O, Parekh A, Taylor R, Wolf J, Zimrin A, Strome S, Ord R, Cullen KJ.
    Int J Radiat Oncol Biol Phys; 2012 Apr 01; 82(5):1845-50. PubMed ID: 21601372
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Induction chemotherapy followed by concomitant TFHX chemoradiotherapy with reduced dose radiation in advanced head and neck cancer.
    Haraf DJ, Rosen FR, Stenson K, Argiris A, Mittal BB, Witt ME, Brockstein BE, List MA, Portugal L, Pelzer H, Weichselbaum RR, Vokes EE.
    Clin Cancer Res; 2003 Dec 01; 9(16 Pt 1):5936-43. PubMed ID: 14676118
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Efficacy of Carboplatin/Paclitaxel-Based Radiochemotherapy in Locally Advanced Squamous Cell Carcinoma of Head and Neck.
    Maring S, Elsayad K, Stenner M, Rudack C, Haverkamp U, Rehkämper J, Wardelmann E, Eich HT.
    Oncol Res Treat; 2018 Dec 01; 41(12):736-743. PubMed ID: 30419553
    [Abstract] [Full Text] [Related]

  • 13. [SIB-IMRT radiotherapy given concomitantly with cisplatin for locally advanced squamous cell head and neck cancer (SCHNC). Evaluation of the early results and toxicity].
    Kiprian D, Jarząbski A, Pawłowska B, Michalski W, Kawecki A.
    Otolaryngol Pol; 2011 Sep 01; 65(5 Suppl):117-25. PubMed ID: 22000261
    [Abstract] [Full Text] [Related]

  • 14. Continuous-course reirradiation with concurrent carboplatin and paclitaxel for locally recurrent, nonmetastatic squamous cell carcinoma of the head-and-neck.
    Kharofa J, Choong N, Wang D, Firat S, Schultz C, Sadasiwan C, Wong S.
    Int J Radiat Oncol Biol Phys; 2012 Jun 01; 83(2):690-5. PubMed ID: 22112556
    [Abstract] [Full Text] [Related]

  • 15. Induction paclitaxel, carboplatin, and infusional 5-FU followed by concurrent radiation therapy and weekly paclitaxel/carboplatin in the treatment of locally advanced head and neck cancer: a phase II trial of the Minnie Pearl Cancer Research Network.
    Hainsworth JD, Meluch AA, McClurkan S, Gray JR, Stroup SL, Burris HA, Yardley DA, Bradof JE, Yost K, Ellis JK, Greco FA.
    Cancer J; 2002 Jun 01; 8(4):311-21. PubMed ID: 12184409
    [Abstract] [Full Text] [Related]

  • 16. Hypothyroidism as a consequence of intensity-modulated radiotherapy with concurrent taxane-based chemotherapy for locally advanced head-and-neck cancer.
    Diaz R, Jaboin JJ, Morales-Paliza M, Koehler E, Phillips JG, Stinson S, Gilbert J, Chung CH, Murphy BA, Yarbrough WG, Murphy PB, Shyr Y, Cmelak AJ.
    Int J Radiat Oncol Biol Phys; 2010 Jun 01; 77(2):468-76. PubMed ID: 19577867
    [Abstract] [Full Text] [Related]

  • 17. Weekly carboplatin and paclitaxel followed by concomitant paclitaxel, fluorouracil, and hydroxyurea chemoradiotherapy: curative and organ-preserving therapy for advanced head and neck cancer.
    Vokes EE, Stenson K, Rosen FR, Kies MS, Rademaker AW, Witt ME, Brockstein BE, List MA, Fung BB, Portugal L, Mittal BB, Pelzer H, Weichselbaum RR, Haraf DJ.
    J Clin Oncol; 2003 Jan 15; 21(2):320-6. PubMed ID: 12525525
    [Abstract] [Full Text] [Related]

  • 18. Feasibility and toxicity of concurrent chemoradiation for elderly patients with head and neck cancer.
    Daly ME, Lau DH, Farwell DG, Luu Q, Donald PJ, Chen AM.
    Am J Otolaryngol; 2013 Jan 15; 34(6):631-5. PubMed ID: 23954137
    [Abstract] [Full Text] [Related]

  • 19. Phase I dose-finding study of paclitaxel with panitumumab, carboplatin and intensity-modulated radiotherapy in patients with locally advanced squamous cell cancer of the head and neck.
    Wirth LJ, Allen AM, Posner MR, Haddad RI, Li Y, Clark JR, Busse PM, Chan AW, Goguen LA, Norris CM, Annino DJ, Tishler RB.
    Ann Oncol; 2010 Feb 15; 21(2):342-347. PubMed ID: 19892746
    [Abstract] [Full Text] [Related]

  • 20. A multicenter phase II trial of paclitaxel, carboplatin, and cetuximab followed by chemoradiotherapy in patients with unresectable locally advanced squamous cell carcinoma of the head and neck.
    Enokida T, Ogawa T, Homma A, Okami K, Minami S, Nakanome A, Shimizu Y, Maki D, Ueda Y, Fujisawa T, Motegi A, Ohkoshi A, Taguchi J, Ebisumoto K, Nomura S, Okano S, Tahara M.
    Cancer Med; 2020 Mar 15; 9(5):1671-1682. PubMed ID: 31943834
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.